High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells
- PMID: 3500055
- DOI: 10.1002/eji.1830171008
High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells
Abstract
The human 26-kDa glycoprotein (26K) is a cytokine produced by lymphoid as well as nonlymphoid cells. So far it is active as (a) a potent hybridoma and plasmacytoma growth factor on mouse cells, (b) a B cell differentiating factor on human cells, and (c) (for some authors) an interferon (IFN). Internally labeled recombinant human 26K, obtained by translation of mRNA in Xenopus oocytes, was used to investigate the presence of specific receptors for this new cytokine and to analyze its binding to responsive cells. The results indicate that (a) the 26K-responsive human lymphoblastoid CESS cells express about 1500 high-affinity (Kd = 30 pM) binding sites for this cytokine, (b) this binding is not competed for by interleukin (IL)1, IL2, tumor necrosis factor (TNF), IFN-alpha 2, IFN-beta or IFN-gamma, and (c) these 26K-binding sites are different from the classical type I (alpha-beta) IFN receptors by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Similar articles
-
The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor.J Immunol. 1987 Sep 15;139(6):1867-72. J Immunol. 1987. PMID: 3305707
-
IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.J Immunol. 1989 Mar 15;142(6):1922-8. J Immunol. 1989. PMID: 2784142
-
Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.J Immunol. 1988 Mar 1;140(5):1566-70. J Immunol. 1988. PMID: 3279118
-
A multifunctional cytokine (IL-6/BSF-2) and its receptor.Int Arch Allergy Appl Immunol. 1989;88(1-2):29-33. doi: 10.1159/000234743. Int Arch Allergy Appl Immunol. 1989. PMID: 2651317 Review.
-
Human interferon-beta 2.J Interferon Res. 1987 Oct;7(5):521-7. doi: 10.1089/jir.1987.7.521. J Interferon Res. 1987. PMID: 3316421 Review. No abstract available.
Cited by
-
Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266.Biochem J. 1995 Jul 1;309 ( Pt 1)(Pt 1):175-80. doi: 10.1042/bj3090175. Biochem J. 1995. PMID: 7619053 Free PMC article.
-
Interleukin-6 and the acute phase response.Biochem J. 1990 Feb 1;265(3):621-36. doi: 10.1042/bj2650621. Biochem J. 1990. PMID: 1689567 Free PMC article. Review. No abstract available.
-
Surface proteins and glycoproteins of human leucocytes.Biochem J. 1988 Jul 1;253(1):1-26. doi: 10.1042/bj2530001. Biochem J. 1988. PMID: 3048251 Free PMC article. Review. No abstract available.
-
Host defense against infections and inflammations: role of the multifunctional IL-6/IFN-beta 2 cytokine.Experientia. 1989 Jun 15;45(6):549-57. doi: 10.1007/BF01990505. Experientia. 1989. PMID: 2661256 Review.
-
Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes.J Exp Med. 1989 Nov 1;170(5):1537-49. doi: 10.1084/jem.170.5.1537. J Exp Med. 1989. PMID: 2809509 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
